Friday, February 27, 2015

Company announcements: Hoe Leong, Pharmesis Intl, IHH, Courts Asia, SGX

Hoe Leong - Financial Statements and Related Announcement::Full Yearly Results

Announcement Type: Financial Statements
Company: HOE LEONG CORPORATION LTD.
Stock Code/Name: H20 - Hoe Leong

Financial Statements and Related Announcement::Full Yearly Results
Issuer & Securities
Issuer/ ManagerHOE LEONG CORPORATION LTD.
SecuritiesHOE LEONG CORPORATION LTD. - SG1S47927920 - H20
Stapled SecurityNo
Announcement Details
Announcement Title Financial Statements and Related Announcement
Date & Time of Broadcast27-Feb-2015 17:32:02
StatusNew
Announcement Sub TitleFull Yearly Results
Announcement ReferenceSG150227OTHRZQHM
Submitted By (Co./ Ind. Name)Kuah Geok Lin
Designation Chairman & Chief Executive Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)Please refer to the attachment.
Additional Details
For Financial Period Ended31/12/2014
Attachments
HLCL_Q4FYE2014.pdf
Total size =298K



Pharmesis Intl - Financial Statements and Related Announcement::Full Yearly Results

Announcement Type: Financial Statements
Company: PHARMESIS INTERNATIONAL LTD.
Stock Code/Name: P31 - Pharmesis Intl

Financial Statements and Related Announcement::Full Yearly Results
Issuer & Securities
Issuer/ ManagerPHARMESIS INTERNATIONAL LTD.
SecuritiesPHARMESIS INTERNATIONAL LTD. - SG1Q12920787 - P31
Stapled SecurityNo
Announcement Details
Announcement Title Financial Statements and Related Announcement
Date & Time of Broadcast27-Feb-2015 17:36:53
StatusNew
Announcement Sub TitleFull Yearly Results
Announcement ReferenceSG150227OTHRK5RU
Submitted By (Co./ Ind. Name)Mr Wu Xuedan
Designation Executive Director / Chief Executive Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)Please refer to the attachement.
Additional Details
For Financial Period Ended31/12/2014
Attachments
Full_year_2014.pdf
Total size =414K



IHH - General Announcement::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO FORM 29B OF THE COMPANIES ACT, 1965

Announcement Type: General Announcement
Company: IHH HEALTHCARE BERHAD
Stock Code/Name: Q0F - IHH

General Announcement::CHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO FORM 29B OF THE COMPANIES ACT, 1965
Issuer & Securities
Issuer/ ManagerIHH HEALTHCARE BERHAD
SecuritiesIHH HEALTHCARE BERHAD - MYL5225OO007 - Q0F
Stapled SecurityNo
Announcement Details
Announcement Title General Announcement
Date & Time of Broadcast27-Feb-2015 17:22:53
StatusNew
Announcement Sub TitleCHANGES IN SUBSTANTIAL SHAREHOLDER'S INTEREST PURSUANT TO FORM 29B OF THE COMPANIES ACT, 1965
Announcement ReferenceSG150227OTHRYD5A
Submitted By (Co./ Ind. Name)SEOW CHING VOON
DesignationCOMPANY SECRETARY
Description (Please provide a detailed description of the event in the box below)The attached announcement was made on Bursa Malaysia Securities Berhad on 27 February 2015.
Attachments



Courts Asia - Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice

Announcement Type: Share Buy Back-On Market
Company: COURTS ASIA LIMITED
Stock Code/Name: RE2 - Courts Asia

Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice
Issuer & Securities
Issuer/ ManagerCOURTS ASIA LIMITED
SecuritiesCOURTS ASIA LIMITED - SG2F22986069 - RE2
Stapled SecurityNo
Announcement Details
Announcement Title Share Buy Back - Daily Share Buy-Back Notice
Date & Time of Broadcast27-Feb-2015 17:41:25
StatusNew
Announcement Sub TitleDaily Share Buy-Back Notice
Announcement ReferenceSG150227OTHR648U
Submitted By (Co./ Ind. Name)Dr Terence Donald O'Connor
DesignationExecutive Director/Group Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)The renewal of the Share Buy-Back Mandate was approved by the Shareholders at the Annual General Meeting held on 30 July 2014. As at 30 July 2014, the issued share capital of the Company consists of 555,739,109 ordinary shares (excluding treasury shares of 4,260,891). After the share buy-back carried out on 27 February 2015, the issued share capital of the Company is 540,572,720 (excluding the shares repurchased which were held as treasury shares).
Additional Details
Start date for mandate of daily share buy-back30/07/2014
Section A
Maximum number of shares authorised for purchase55,573,910
Purchase made by way of market acquisitionYes
Singapore ExchangeOverseas Exchange
Date of Purchase27/02/2015
Total Number of shares purchased5,000
Number of shares cancelled0
Number of shares held as treasury shares5,000
Price Paid per share
Price Paid per shareSGD 0.465
Total Consideration (including stamp duties, clearing changes etc) paid or payable for the sharesSGD 2,368.8
Section B
Purchase made by way of off-market acquisition on equal access schemeNo
Section C
Cumulative No. of shares purchased to date^NumberPercentage#
By way of Market Acquisition15,763,2002.8364
By way off Market Acquisition on equal access scheme00
Total15,763,2002.8364
#Percentage of company's issued shares excluding treasury shares as at the date of the share buy-back resolution
^From the date on which share buy-back mandate is obtained
Section D
Number of issued shares excluding treasury shares after purchase540,572,720
Number of treasury shares held after purchase19,427,280



SGX - General Announcement::SGX names Tan Boon Gin as new Chief Regulatory Officer

Announcement Type: General Announcement
Company: SINGAPORE EXCHANGE LIMITED
Stock Code/Name: S68 - SGX

General Announcement::SGX names Tan Boon Gin as new Chief Regulatory Officer
Issuer & Securities
Issuer/ ManagerSINGAPORE EXCHANGE LIMITED
SecuritiesSINGAPORE EXCHANGE LIMITED - SG1J26887955 - S68
Stapled SecurityNo
Announcement Details
Announcement Title General Announcement
Date & Time of Broadcast27-Feb-2015 17:32:57
StatusNew
Announcement Sub TitleSGX names Tan Boon Gin as new Chief Regulatory Officer
Announcement ReferenceSG150227OTHRN5N0
Submitted By (Co./ Ind. Name)Carolyn Lim
DesignationVP, Marketing & Comms
Description (Please provide a detailed description of the event in the box below)Singapore Exchange (SGX) is pleased to announce the appointment of Tan Boon Gin as Chief Regulatory Officer effective 15 June 2015. Mr Tan is currently Director of the Commercial Affairs Department.

Following the departure of Richard Teng on 28 February 2015, in the interim, Yeo Lian Sim, special adviser to SGX and previously Chief Risk and Regulatory Officer, will be appointed as Chief Regulatory Officer from 1 March 2015 to 14 June 2015.

I am pleased to welcome Boon Gin to SGX. His extensive experience and knowledge of Singapore s regulatory and corporate investigation environment will be a significant addition to our bench strength as we continue to enhance our markets and regulatory function. I am confident Boon Gin will contribute to the success of SGX as a world-class market operator and regulator, said Magnus Bocker, CEO of SGX.

Mr Tan was previously a Justices Law Clerk at Singapore s Supreme Court and a Deputy Public Prosecutor at the Attorney-General's Chambers, where he specialised in corruption and white-collar crime, before leaving to practise at Messrs Sullivan & Cromwell in New York.

He later served as a District Judge at Singapore s Subordinate Courts before being seconded to the Monetary Authority of Singapore, where he held appointments as Director of the Enforcement Division, Director of the Corporate Finance Division and Executive Director of the Investment Intermediaries Department.

He is an advocate and solicitor and holds degrees from the University of Cambridge and Harvard Law School.
Mr Tan was awarded the Public Administration (Silver) Medal in 2010.

-End-
Attachments



No comments:

Post a Comment